Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-24-024045

Options or other derivatives

  • Chief Executive Officer acquired 1,132,871 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Fortney Kristen Chief Executive Officer 2024-09-25 Grant or award · Stock Option (Right to Buy) +424,827 424,827 D: show line 1 in the form
Fortney Kristen Chief Executive Officer 2024-04-17 Grant or award · Stock Option (Right to Buy) +708,044 708,044 D: show line 2 in the form
Loading xslF345X05/form4-09272024_080922.xml…